慢性心力衰竭的循证诊疗与管理
全新正版 假一赔十 可开发票
￥ 266.2 6.7折 ￥ 398 全新
库存13件
北京东城
认证卖家担保交易快速发货售后保障
作者徐俊波 编
出版社科学技术文献出版社
ISBN9787523516478
出版时间2024-09
装帧精装
开本16开
定价398元
货号1203422285
上书时间2024-11-14
商品详情
- 品相描述：全新
- 商品描述
-
作者简介
主编徐俊波主任医师，系四川省“天府名医”、四川省学术和技术带头人、四川省卫生健康领军人才、四川省卫健委学术技术带头人、成都市卫健委学术技术带头人、享受成都市人民政府特殊津、中国医院协会2016年优秀医院院长、“国家卫健委医疗管理服务指导专家库”成员、中国医院协会国际医疗服务与管理专业委员会常务委员，中国高血压联盟理事，中国高血压及相关疾病中青年专家论坛CHIEF成员、中国心脏康复联盟四川分盟主任委员、四川省医师协会副会长、四川省医师协会心血管专业委员会主任委员、、四川省医学会心血管专业委员会副主任委员、四川省中西医结合心血管专业委员会主任委员，成都市医学会心血管专业委员会副主任委员，《心血管病学进展》主编。主持/主研省市各级课题、横向课题、国际多中心研究10多项，获省、市科技进步奖4项，授权国家发明专利6项，实用新型专利6项。发表学术论文100余篇，SCI收录论文10多篇，中文核心期刊论文逾40篇，。主编/参编学术专著4部，已培养硕士研究生12名。
目录
第一章 慢性心力衰竭的流行病学 ······················································································· 1
第二章 慢性心力衰竭的病理生理机制 ················································································ 10
第三章 慢性心力衰竭的诊断和评估 ··················································································· 17
第一节 慢性心力衰竭诊断概述 ··················································································· 17
第二节 超声心动图诊断 ···························································································· 21
第三节 放射学诊断 ·································································································· 31
第四节 慢性心力衰竭的评估 ······················································································ 56
第四章 慢性心力衰竭的药物治疗 ······················································································ 86
第一节 血管紧张素转换酶（受体、受体脑啡肽酶）抑制剂 ··············································· 86
第二节 β受体阻滞剂 ······························································································ 105
第三节 钠.-葡萄糖耦联转运体 2抑制剂 ······································································ 121
第四节 盐皮质激素受体拮抗剂 ················································································· 130
第五节 正性肌力药物 ····························································································· 146
第六节 利尿剂······································································································· 158
第七节 药物方案的调整及优化 ················································································· 162
第五章 慢性心力衰竭的非药物治疗 ················································································· 168
第一节 连续性肾脏替代治疗 ···················································································· 168
第二节 起搏治疗 ··································································································· 179
第三节 心脏收缩力调节器 ······················································································· 197
第四节 主动脉内球囊反搏 ······················································································· 205
第五节 体外膜肺氧合 ······························································································211
第六节 微轴向心室辅助装置（以 Impella为例） ··························································· 219
第七节 颈动脉窦刺激及交感节神经消融 ····································································· 230
第八节 二尖瓣外科成形术及介入技术 ········································································ 238
第九节 左心室减容术 ····························································································· 249
第十节 心室辅助装置 ····························································································· 257
第十一节 心脏移植 ································································································ 265
第六章 慢性心力衰竭合并其他疾病 ················································································· 276
第一节 高血压······································································································· 276
第二节 冠心病······································································································· 284
第三节 心房颤动 ··································································································· 293
第四节 糖尿病······································································································· 316
第五节 肥厚型心肌病 ····························································································· 330
第六节 扩张型心肌病 ····························································································· 340
第七节 心脏淀粉样变性 ·························································································· 360
第八节 炎症性心肌病 ····························································································· 366
第九节 心肾综合征 ································································································ 376
第十节 呼吸系统疾病 ····························································································· 387
第十一节 甲状腺疾病 ····························································································· 404
第十二节 肺动脉高压 ····························································································· 413
第十三节 瓣膜性心脏病 ·························································································· 431
第十四节 抗肿瘤治疗相关心力衰竭 ··········································································· 443
第十五节 结缔组织疾病 ·························································································· 455
第七章 慢性心力衰竭的康复治疗 ···················································································· 463
第一节 体力活动的益处和风险 ················································································· 463
第二节 运动前筛查及评估 ······················································································· 464
第三节 运动测试和结果分析 ···················································································· 469
第四节 运动处方 ··································································································· 472
第五节 促进主动运动的策略 ···················································································· 475
第八章 慢性心力衰竭的全程管理 ···················································································· 483
第九章 干细胞治疗在心力衰竭中的应用 ··········································································· 491
附录 心力衰竭相关的重要临床研究 ················································································· 498
内容摘要
心血管疾病已经成为我国城乡居民的首要死亡原因，给人民和社会的带来的经济负担日益加重。其中，心力衰竭作为诸多心血管疾病的终末阶段，是二十一世纪最重要的心血管病之一，其死亡率和癌症相当，是严重影响人民健康的重要公共卫生问题。近年来，心血管病学领域取得了巨大进展。基础医学及相关学科的发展，进一步丰富了对心血管疾病发病和病理生理机制的认识。心力衰竭领域的进展一日千里，有鉴于此，我们亟需一本能反映此领域最新循证医学进展的专著，以供广大心血管专科医师参考。本书围绕慢性心力衰竭这个主题，重点关注慢性心衰的临床诊疗及管理，介绍慢性心力衰竭的流行病学、病理生理机制最新药物和非药物治疗进展、康复及管理理念，并结合心衰不同病因及合并疾病情况进行介绍，尽可能的反映出近年来慢性心衰领域的前沿诊疗措施和技术。
主编推荐
心血管疾病已经成为我国城乡居民的首要死亡原因，给人民和社会的带来的经济负担日益加重。其中，心力衰竭作为诸多心血管疾病的终末阶段，是二十一世纪最重要的心血管病之一，其死亡率和癌症相当，是严重影响人民健康的重要公共卫生问题。近年来，心血管病学领域取得了巨大进展。基础医学及相关学科的发展，进一步丰富了对心血管疾病发病和病理生理机制的认识。心力衰竭领域的进展一日千里，有鉴于此，我们亟需一本能反映此领域最新循证医学进展的专著，以供广大心血管专科医师参考。本书围绕慢性心力衰竭这个主题，重点关注慢性心衰的临床诊疗及管理，介绍慢性心力衰竭的流行病学、病理生理机制最新药物和非药物治疗进展、康复及管理理念，并结合心衰不同病因及合并疾病情况进行介绍，尽可能的反映出近年来慢性心衰领域的前沿诊疗措施和技术。
相关推荐
— 没有更多了 —
以下为对购买帮助不大的评价